…cyclosporine, azathioprine), 1,957 with “non-cytotoxic” DMARDs, and 10,617 with glucocorticoids) with a total exposure time of 5,676 patient-years. The mean follow-up time per group ranged from 0.20 to 1.29 years….
Search Results for: HPE0-V27 Certification Book Torrent πΊ Exam HPE0-V27 Tutorial π΄ HPE0-V27 Passguide π Open β www.pdfvce.com β enter β HPE0-V27 π ° and obtain a free download πExam HPE0-V27 Answers
MMF vs AZA for SLE Nephritis
Vertebroplasty not Superior to Placebo for the Treatment of Painful Osteoporotic Fractures
…a true placebo in blinded fashion. To address this knowledge gap, two concurrently published studies (Buchbinder et al and Kalmes et all. NEJM 2009; 361(6): 557-568 and 569-579) report the…
Temporal Trends in the Maintenance of Bone Health among Chronic Glucocorticoid Users Improving, but Fall Short of Recommendations
…initiation of glucocorticoid therapy (1996-1997, 1998-1999, 2000-2001), glucocorticoid dose, non-traumatic fracture history, and specialty of provider recommending bone-health strategies. Results 3125 patients initiating glucocorticoid therapy were included. Among the three…
Predictors of Increased Carotid Atherosclerosis in RA Patients
…carotid plaque in individuals with RA compared to non-RA controls. Here, Roman et al. (Ann Intern Med 2006; 144:249) confirm this risk for the first time. Methods Adult RA patients…
TNF Inhibitor Use Associated with a Reduced Risk of Myocardial Infarction in Rheumatoid Arthritis Patients?
…of corticosteroid treatment (19.3% vs. 43.7%; p <0.001), and were slightly less frequently treated with NSAIDs (62% vs. 66%; p = 0.001). Median follow-up time was relatively short; 1.66 years…